SCHEMBL20934096

SCHEMBL20934096

C=c1sc2ccccc2c1=C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.55
▸ ALDH1A1 P00352 5/20 0.39
▸ MAPT P10636 5/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ HPGD P15428 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ LOXL2 Q9Y4K0 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.37
▸ LMNA P02545 3/20 0.37
▸ DDAH1 O94760 1/20 0.37
▸ CASP3 P42574 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ CACNA1B Q00975 1/20 0.37
▸ APBA1 Q02410 1/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ LIMK1 P53667 2/20 0.35
▸ MCL1 Q07820 1/20 0.35
▸ IKBKB O14920 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19802482 0.76 GPR3 (0.35) GPR3ALDH1A1MAPTRAB9AHPGD
SCHEMBL18698185 0.73 GPR3 (0.46) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL30167635 0.72 GPR3 (1.00) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL13294 0.72 GPR3 (1.00) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL14659543 0.72 GPR3 (1.00) GPR3ALDH1A1MAPTRAB9AHPGD
SCHEMBL24589386 0.72 GPR3 (0.44) GPR3ALDH1A1MAPTRAB9AHPGD
SCHEMBL24078454 0.72 GPR3 (0.44) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL11351112 0.70 GPR3 (0.82) GPR3ALDH1A1MAPTRAB9AHPGD
SCHEMBL24426308 0.70 GPR3 (0.43) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL3101427 0.69 GPR3 (0.93) GPR3ALDH1A1MAPTRAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172052-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THEREOF LG DISPLAY CO., LTD (KR) 2023-06-01 — — US disclosed
US-20220209139-A1 ORGANIC METAL COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND LG DISPLAY CO., LTD (KR) 2022-06-30 — — US disclosed
WO-2019078461-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME 주식회사 엘지화학 2019-04-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220209139-A1 ORGANIC METAL COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND OCIAD1, OCIAD2, OLA1 GPR3 4572/4885ALDH1A1 360/4885MAPT 913/4885
US-20230172052-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THEREOF OCIAD1, APOL1, OCIAD2 GPR3 4108/4885ALDH1A1 390/4885MAPT 594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback